COST-EFFECTIVENESS ANALYSIS COMPARING DABIGATRAN AND ADJUSTED-DOSE WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION

被引：0
|
作者：
Zhao, Y. [1 ]
Lim, L. [1 ]
Coleman, C., I [2 ]
机构：
[1] Yale Griffin Hosp, Derby, CT USA
[2] Univ Connecticut, Sch Pharm, Storrs, CT USA
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.237
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A41 / A41
页数：1
相关论文
共 50 条
  • [31] Cost-Effectiveness of Dabigatran versus Genotype-Guided Management of Warfarin Therapy for Stroke Prevention in Patients with Atrial Fibrillation
    You, Joyce H. S.
    Tsui, Kia K. N.
    Wong, Raymond S. M.
    Cheng, Gergory
    PLOS ONE, 2012, 7 (06):
  • [32] COST-EFFECTIVENESS OF DABIGATRAN VERSUS WARFARIN IN ATRIAL FIBRILLATION MANAGEMENT IN COLOMBIA
    Alfonso-Cristancho, R.
    Herran, S.
    Caicedo, M.
    Gomez, E.
    VALUE IN HEALTH, 2011, 14 (07) : A536 - A537
  • [33] Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in Sweden
    Davidson, Thomas
    Husberg, Magnus
    Janzon, Magnus
    Oldgren, Jonas
    Levin, Lars-Ake
    EUROPEAN HEART JOURNAL, 2013, 34 (03) : 177 - 183
  • [34] Improve Warfarin Therapy or Use Dabigatran for Patients with Atrial Fibrillation - A Cost-Effectiveness Analysis
    You, Joyce H.
    Tsui, Kia K.
    Wong, Raymond S.
    Cheng, Gregory
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1334 - 1334
  • [35] Cost-effectiveness of Dabigatran for Stroke Prevention in Non-valvular Atrial Fibrillation in Spain
    Gonzalez-Juanatey, Jose R.
    Alvarez-Sabin, Jose
    Lobos, Jose M.
    Martinez-Rubio, Antoni
    Reverter, Joan C.
    Oyagueez, Itziar
    Gonzalez-Rojas, Nuria
    Becerra, Virginia
    REVISTA ESPANOLA DE CARDIOLOGIA, 2012, 65 (10): : 901 - 910
  • [36] ANALYSIS OF COST-EFFECTIVENESS OF WARFARIN VS. DABIGATRAN ETEXILATE IN ATRIAL FIBRILLATION IN ECUADOR
    Penaherrera, E.
    Tettamanti, D.
    Aguirre, F.
    Puyol, L. F.
    Cardenas, E.
    Torres, G.
    Herran, S.
    VALUE IN HEALTH, 2015, 18 (07) : A830 - A830
  • [37] Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation in Taiwan
    Chang, Chia-Hsien
    Yang, Yea-Huei Kao
    Chen, Jyh-Hong
    Lin, Li-Jen
    THROMBOSIS RESEARCH, 2014, 133 (05) : 782 - 789
  • [38] Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation - Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study
    Gullov, AL
    Koefoed, BG
    Petersen, P
    Pedersen, TS
    Andersen, ED
    Godtfredsen, J
    Boysen, G
    ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (14) : 1513 - 1521
  • [39] How Big Is the Impact of the Warfarin Cost on the Cost-Effectiveness of Rivaroxoban for Stroke Prevention in Atrial Fibrillation?
    Sanaei, Omid
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (09): : 1384 - 1385
  • [40] Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
    Freeman, James V.
    Turakhia, Mintu P.
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (08) : 570 - 571
12345